S

Shenzhen Hepalink Pharmaceutical Group Co Ltd
SZSE:002399

Watchlist Manager
Shenzhen Hepalink Pharmaceutical Group Co Ltd
SZSE:002399
Watchlist
Price: 11.05 CNY 0.55% Market Closed
Market Cap: 13.8B CNY
Have any thoughts about
Shenzhen Hepalink Pharmaceutical Group Co Ltd?
Write Note

Relative Value

The Relative Value of one Shenzhen Hepalink Pharmaceutical Group Co Ltd stock under the Base Case scenario is 15.75 CNY. Compared to the current market price of 11.05 CNY, Shenzhen Hepalink Pharmaceutical Group Co Ltd is Undervalued by 30%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
15.75 CNY
Undervaluation 30%
Relative Value
Price
S
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
66
vs Industry
48
Median 3Y
2.5
Median 5Y
2.9
Industry
2.5
Forward
2.4
vs History
vs Industry
8
Median 3Y
28.9
Median 5Y
25.5
Industry
21.8
Forward
19.9
vs History
30
vs Industry
39
Median 3Y
-16.6
Median 5Y
-20.2
Industry
16.1
vs History
30
vs Industry
Median 3Y
-8.9
Median 5Y
-8.9
Industry
23.8
vs History
84
vs Industry
61
Median 3Y
1.3
Median 5Y
1.6
Industry
2.1
vs History
73
vs Industry
43
Median 3Y
2.7
Median 5Y
3
Industry
2.7
Forward
2.5
vs History
77
vs Industry
27
Median 3Y
8.4
Median 5Y
9.6
Industry
5.2
vs History
vs Industry
18
Median 3Y
20.3
Median 5Y
24.2
Industry
13.5
Forward
11.5
vs History
vs Industry
22
Median 3Y
20.3
Median 5Y
24.2
Industry
16.8
Forward
22.7
vs History
30
vs Industry
38
Median 3Y
-19
Median 5Y
-21.5
Industry
15.2
vs History
23
vs Industry
26
Median 3Y
-17.2
Median 5Y
-24.1
Industry
19.3
vs History
82
vs Industry
64
Median 3Y
1
Median 5Y
1.3
Industry
1.9

Multiples Across Competitors

Competitors Multiples
Shenzhen Hepalink Pharmaceutical Group Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Shenzhen Hepalink Pharmaceutical Group Co Ltd
SZSE:002399
13.8B CNY 2.5 -94.2 -77.8 -77.8
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
756.2B USD 18.5 89.9 48.1 53.7
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
2.7T DKK 10.2 29 20.2 23
US
Johnson & Johnson
NYSE:JNJ
350.6B USD 4 23.7 11.5 14.9
US
Merck & Co Inc
NYSE:MRK
252B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
200.1B CHF 3.4 17.4 9.8 11.6
UK
AstraZeneca PLC
LSE:AZN
161.8B GBP 4.1 31.5 169.4 253.8
CH
Novartis AG
SIX:NOVN
171.5B CHF 3.8 10.8 9.4 13.1
US
Pfizer Inc
NYSE:PFE
151.5B USD 2.5 35.4 10.5 15.9
P/E Multiple
Earnings Growth P/E to Growth
CN
S
Shenzhen Hepalink Pharmaceutical Group Co Ltd
SZSE:002399
Average P/E: 32.3
Negative Multiple: -94.2
N/A N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
89.9
446%
0.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
29
86%
0.3
US
Johnson & Johnson
NYSE:JNJ
23.7
-23%
N/A
US
Merck & Co Inc
NYSE:MRK
20.7
7 300%
0
CH
Roche Holding AG
SIX:ROG
17.4
54%
0.3
UK
AstraZeneca PLC
LSE:AZN
31.5
177%
0.2
CH
Novartis AG
SIX:NOVN
10.8
31%
0.3
US
Pfizer Inc
NYSE:PFE
35.4
719%
0
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
S
Shenzhen Hepalink Pharmaceutical Group Co Ltd
SZSE:002399
Average EV/EBITDA: 459.5
Negative Multiple: -77.8
N/A N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 459 134.4 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
48.1
195%
0.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
151%
25.5
DK
Novo Nordisk A/S
CSE:NOVO B
20.2
84%
0.2
US
Johnson & Johnson
NYSE:JNJ
11.5
14%
0.8
US
Merck & Co Inc
NYSE:MRK
10.5
331%
0
CH
Roche Holding AG
SIX:ROG
9.8
23%
0.4
UK
AstraZeneca PLC
LSE:AZN
169.4
64%
2.7
CH
Novartis AG
SIX:NOVN
9.4
8%
1.2
US
Pfizer Inc
NYSE:PFE
10.5
31%
0.3
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
S
Shenzhen Hepalink Pharmaceutical Group Co Ltd
SZSE:002399
Average EV/EBIT: 2 011.2
Negative Multiple: -77.8
N/A N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 046 864.6 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
53.7
211%
0.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
675%
26.2
DK
Novo Nordisk A/S
CSE:NOVO B
23
83%
0.3
US
Johnson & Johnson
NYSE:JNJ
14.9
28%
0.5
US
Merck & Co Inc
NYSE:MRK
12.5
675%
0
CH
Roche Holding AG
SIX:ROG
11.6
28%
0.4
UK
AstraZeneca PLC
LSE:AZN
253.8
131%
1.9
CH
Novartis AG
SIX:NOVN
13.1
58%
0.2
US
Pfizer Inc
NYSE:PFE
15.9
68%
0.2

See Also

Discover More
Back to Top